[PDF][PDF] COVID-19 drug therapy
T Smith, J Bushek, A LeClaire, T Prosser - Elsevier, 2020 - repository.phb.ac.id
• There are no specific therapies approved by the US Food and Drug Administration (FDA)
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
Anti COVID-19 drugs: need for more clinical evidence and global action
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019
A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
Clinical management of COVID-19: a review of pharmacological treatment options
AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni… - Internal and emergency …, 2021 - Springer
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2,
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
COVID-19: a brief overview of the discovery clinical trial
JJ Vanden Eynde - Pharmaceuticals, 2020 - mdpi.com
The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The
urgency of the situation favors a repurposing of active drugs but not only antivirals. This short …
urgency of the situation favors a repurposing of active drugs but not only antivirals. This short …